Organon & Co. (OGN)
13.79
+0.05
(+0.36%)
USD |
NYSE |
Oct 07, 16:00
13.78
-0.01
(-0.07%)
Pre-Market: 20:00
Organon Profit Margin (Quarterly) : 6.93% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.93% |
| March 31, 2026 | 10.00% |
| December 31, 2025 | -13.60% |
| September 30, 2025 | 9.99% |
| June 30, 2025 | 9.10% |
| March 31, 2025 | 5.75% |
| December 31, 2024 | 6.85% |
| September 30, 2024 | 22.69% |
| June 30, 2024 | 12.13% |
| March 31, 2024 | 12.39% |
| December 31, 2023 | 34.17% |
| September 30, 2023 | 3.82% |
| June 30, 2023 | 15.05% |
| Date | Value |
|---|---|
| March 31, 2023 | 11.51% |
| December 31, 2022 | 7.27% |
| September 30, 2022 | 14.77% |
| June 30, 2022 | 14.76% |
| March 31, 2022 | 22.21% |
| December 31, 2021 | 11.77% |
| September 30, 2021 | 20.19% |
| June 30, 2021 | 26.64% |
| March 31, 2021 | 25.68% |
| December 31, 2020 | 23.10% |
| September 30, 2020 | 34.59% |
| June 30, 2020 | 38.23% |
| March 31, 2020 | 41.49% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | -8.06% |
| Pfizer Inc. | -1.64% |
| Bristol Myers Squibb Co. | 25.54% |
| Harmony Biosciences Holdings, Inc. | 28.87% |
| ANI Pharmaceuticals, Inc. | 8.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 24.30% |
| Return on Assets | 1.58% |
| Return on Invested Capital | 2.18% |
| Gross Profit Margin (Quarterly) | 54.36% |
| Operating Margin (Quarterly) | 20.73% |
| Return on Net Operating Assets | 2.14% |